NIFTY 50 23344.75 ▲ (0.61%)
NIFTY NEXT 50 65106.15 ▲ (0.08%)
NIFTY 100 24048.8 ▲ (0.51%)
NIFTY MIDCAP 100 55106.2 ▲ (0.91%)
NIFTY SMALLCAP 100 17864.65 ▲ (1.09%)
NIFTY SMALLCAP 250 16841.4 ▲ (0.84%)
NIFTY MIDCAP SELECT 12356.5 ▲ (0.87%)
NIFTY TOTAL MARKET 12304.6 ▲ (0.6%)
NIFTY BANK 49350.8 ▲ (1.67%)
SENSEX 77073.44 ▲ (0.59%)
BSE BANKEX 56036.23 ▲ (2.03%)

Metropolis Healthcare : Q4 2024 Financial Quarterly Report : YoY Sales Up 17.15 %, QoQ Up 13.7 %

Image is loading

Highlights

  • Sales over the Year and quarter: The company experienced a substantial growth of 17.15 % in the past year, substantial increase in net sales/revenue by 13.7 %.
  • Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 106.5 %. Marginal increase in other income during this quarter, up by 9.96%.
  • Profit over the Year and quarter: Significant improvement in profitability for Metropolis Healthcare Limited. Notable increase of 9.07 % in net profit Year to Year, Metropolis Healthcare Limited’s profitability increased by 33.85 % in this quarter.
  • EPS over the Year and quarter: EPS increased by 9.22 % Year to Year. EPS increased by 34.15 % in previous quarter. Positive impact on shareholders.

The comprehensive analytics outlining the performance and outlook of Metropolis Healthcare Limited”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 282.546 Cr Rs. 291.117 Cr Rs. 331 Cr + 13.7 % + 17.15 %
Expenses Rs. 212.25 Cr Rs. 226.27 Cr Rs. 251.02 Cr + 10.94 % + 18.27 %
Operating Profit Rs. 70.3 Cr Rs. 64.85 Cr Rs. 79.98 Cr + 23.33 % + 13.77 %
OPM % 24.88 % 22.28 % 24.16 % + 1.88 % -0.72 %
Other Income Rs. 1.23 Cr Rs. 2.31 Cr Rs. 2.54 Cr + 9.96 % + 106.5 %
Interest Rs. 6.18 Cr Rs. 5.31 Cr Rs. 5.57 Cr + 4.9 % -9.87 %
Depreciation Rs. 23.44 Cr Rs. 24.99 Cr Rs. 26.42 Cr + 5.72 % + 12.71 %
Profit before tax Rs. 41.91 Cr Rs. 36.86 Cr Rs. 50.53 Cr + 37.09 % + 20.57 %
Tax % 20.08 % 25.96 % 27.72 % + 1.76 % + 7.64 %
Net Profit Rs. 33.49 Cr Rs. 27.29 Cr Rs. 36.53 Cr + 33.86 % + 9.08 %
EPS in Rs Rs. 6.49 Rs. 5.28 Rs. 7.08 + 34.09 % + 9.09 %


Today, we’re looking at Metropolis Healthcare Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 17.15 %. However, it did see a marginal increase of 13.7 % from the previous quarter. Expenses ticked up slightly by 10.94 % quarter-on-quarter, aligning with the annual rise of 18.27 %. Operating profit, while up 13.77 % compared to last year, faced a quarter-on-quarter increase of 23.33 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.72 %, but an expansion of 1.88 % sequentially. Other income rose by 9.96 % compared to the last quarter, despite an annual growth of 106.5 %. Interest expenses surged remarkably by 4.9 % from the previous quarter, yet the year-over-year decrease remains at a moderate -9.87 %. Depreciation costs climbed by 5.72 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 12.71 %. Profit before tax grew annually by 20.57 % but saw an increase from the preceding quarter by 37.09 %.
Tax expenses as a percentage of profits increased slightly by 7.64 % compared to last year, with a more notable quarter-on-quarter increase of 1.76 %. Net profit rose by 9.08 % year-on-year but experienced a 33.86 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 9.09 % but a quarterly rise of 34.09 %. In summary, Metropolis Healthcare Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 282.546 Cr Rs. 291.117 Cr Rs. 331 Cr + 13.7 % + 17.15 %
Expenses Rs. 212.25 Cr Rs. 226.27 Cr Rs. 251.02 Cr + 10.94 % + 18.27 %
Operating Profit Rs. 70.3 Cr Rs. 64.85 Cr Rs. 79.98 Cr + 23.33 % + 13.77 %
Net Profit Rs. 33.49 Cr Rs. 27.29 Cr Rs. 36.53 Cr + 33.86 % + 9.08 %
EPS in Rs Rs. 6.49 Rs. 5.28 Rs. 7.08 + 34.09 % + 9.09 %


In reviewing Metropolis Healthcare Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 17.15 % year-on-year growth, however, there was a minor increase of 13.7 % from the previous quarter. Expenses rose by 18.27 % compared to the previous year, with a 10.94 % increase quarter-on-quarter. Operating Profit surged by 13.77 % annually, and saw a 23.33 % increase from the last quarter.
Net Profit showed yearly increase of 9.08 %, and experienced a 33.86 % increase from the previous quarter. Earnings Per Share (EPS) rose by 9.09 % annually, however rose by 34.09 % compared to the last quarter. In essence, while Metropolis Healthcare Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”Metropolis Healthcare “]

Related Post